Insider Shareholders with Direct Ownership of Keros Therapeutics, Inc. (KROS)
This section provides a comprehensive overview of the insiders with direct ownership of Keros Therapeutics, Inc. (KROS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Keros Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jasbir Seehra
CHIEF EXECUTIVE OFFICER |
9,000 | 0 | 252,856 $4.33 Million | 2 |
Apr 08, 2023
Added 1.56%
|
|
Jennifer Lachey
Chief Scientific Officer |
199,859 | 132,750 | 95,100 $1.63 Million | 44 |
Jul 15, 2022
Reduced 32.62%
|
| 1,191 | 0 | 8,293 $141,976 | 1 |
Jun 01, 2022
Added 50.0%
|
|
|
Christopher Rovaldi
CHIEF OPERATING OFFICER |
2,592 | 2,592 | 0 $0 | 4 |
Apr 06, 2022
Reduced 100.0%
|
|
Keith Regnante
CHIEF FINANCIAL OFFICER |
80,000 | 80,000 | 0 $0 | 6 |
Nov 04, 2023
Reduced 100.0%
|
|
Claudia Ordonez
Chief Medical Officer |
5,000 | 5,000 | 0 $0 | 10 |
Jun 11, 2021
Reduced 100.0%
|